BioNTech SE Sponsored ADR BNTX
BioNTech SE (BNTX) is a global biotechnology company pioneering the development of next-generation immunotherapies for cancer and infectious diseases. The company leverages a diverse suite of cutting-edge technology platforms, including mRNA, cell therapies, and protein-based therapeutics, to create targeted treatments that aim to harness the body's immune system. BioNTech serves patients worldwide through its research, clinical development, and commercialization efforts, often in collaboration with major pharmaceutical partners such as Pfizer, Genentech, and Genmab. Its business model combines internal research and development with strategic partnerships to advance its pipeline, generate revenue from commercialized products like the COVID-19 vaccine, and reinvest in expanding its therapeutic portfolio across oncology and infectious diseases.
LSTM Forecast
Forecast model is not trained yet for this market.
Train and backfill the LSTM forecast to surface a directional view here.